Literature DB >> 9352962

Drug-induced cardiac arrhythmias: incidence, prevention and management.

J C Doig1.   

Abstract

Drugs can cause cardiac arrhythmias in a number of clinical situations, and many of the implicated agents are used to treat non-cardiac conditions. These adverse effects are frequently idiosyncratic, but are often mediated via triggered activity causing torsade de pointes. Drugs being used for treatment of cardiac conditions may promote arrhythmias by re-entrant mechanisms or via triggered activity. Many drugs may cause cardiac arrhythmic complications when taken in excessive amounts. Keys to reducing the incidence of drug-induced cardiac arrhythmias include increased awareness among the medical, pharmaceutical and nursing professions of the potential problems in using certain agents, especially in specific situations. Appropriate monitoring when such treatment is essential and, after diagnosis, prompt withdrawal of the offending agent and treatment for the arrhythmia should be initiated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352962     DOI: 10.2165/00002018-199717040-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.228


  83 in total

1.  Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

Authors:  S E Coplen; E M Antman; J A Berlin; P Hewitt; T C Chalmers
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

Review 2.  Proarrhythmic actions of antiarrhythmic drugs: a review.

Authors:  T J Campbell
Journal:  Aust N Z J Med       Date:  1990-06

3.  Controlled-release oral salbutamol and cardiac arrhythmias in asthmatic patients.

Authors:  M Malerba; A Politi; B Filippi; E Boni; V Grassi
Journal:  Chest       Date:  1993-09       Impact factor: 9.410

Review 4.  Magnesium therapy in ventricular arrhythmias.

Authors:  A Keren; D Tzivoni
Journal:  Pacing Clin Electrophysiol       Date:  1990-07       Impact factor: 1.976

5.  Bronchodilators and acute cardiac death.

Authors:  S Suissa; B Hemmelgarn; L Blais; P Ernst
Journal:  Am J Respir Crit Care Med       Date:  1996-12       Impact factor: 21.405

Review 6.  Cardiotoxicity of interferon. A review of 44 cases.

Authors:  M Sonnenblick; A Rosin
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

7.  Early afterdepolarizations and arrhythmogenesis. Experimental and clinical aspects.

Authors:  N el-Sherif
Journal:  Arch Mal Coeur Vaiss       Date:  1991-02

Review 8.  Magnesium and the heart: antiarrhythmic therapy with magnesium.

Authors:  T Fazekas; B J Scherlag; M Vos; H J Wellens; R Lazzara
Journal:  Clin Cardiol       Date:  1993-11       Impact factor: 2.882

Review 9.  Torsade de pointes. Mechanisms and management.

Authors:  C Napolitano; S G Priori; P J Schwartz
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

10.  Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion.

Authors:  K G Perry; J C Morrison; O A Rust; C A Sullivan; R W Martin; R W Naef
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

View more
  9 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias.

Authors:  Tengxian Liu; Barry S Brown; Ying Wu; Charles Antzelevitch; Peter R Kowey; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2006-04-22       Impact factor: 6.343

3.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 4.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

Review 5.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

Review 6.  Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

7.  The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.

Authors:  Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

8.  Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database.

Authors:  Tarita Murray-Thomas; Meghan E Jones; Deven Patel; Elizabeth Brunner; Chetan C Shatapathy; Stephen Motsko; Tjeerd P Van Staa
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-12-26

9.  Carbamazepine-induced Seizure in a Nonepileptic Child.

Authors:  Rajesh Benny; Vyankatesh Bolegave; Sameer Sadavarte; Vinayak Khatav
Journal:  Ann Indian Acad Neurol       Date:  2017 Oct-Dec       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.